7/5/2008 New York, NY Karla Gale Reuters (www.reuters.com) Human papillomavirus type 16 (HPV-16), which has been linked to cervical cancer, can be detected in human breast milk collected during the early period after a woman delivers her baby, doctors from Finland report. It is possible that HPV DNA present in breast milk may be transmitted to the infant during breast [...]
Continue reading...4. July 2008
7/4/2008 web-based article Matthew Dennis cancerdrugnewsblog.blogspot.com Introgen Therapeutics has submitted a BLA to the FDA, while simultaneously Gendux Molecular (Introgen) has submitted an MAA to the EMEA, both seeking marketing approval for Advexin (INGN 201), the company’s targeted p53 tumour suppressor gene therapy, to treat recurrent, refractory head and neck cancer. INGN 201 represents the first in a new [...]
Continue reading...4. July 2008
7/4/2008 Ottawa, Ontario, Canada Sarah Schmidt Canada.com Graphic health warnings on cigarette packages are failing to move the majority of smokers to quit, a new government survey has found. Over the last five years, the percentage of smokers who say the warnings are ineffective at getting them to try to kick the habit has increased, according to the newly released [...]
Continue reading...3. July 2008
7/3/2008 Salt Lake City, UT press release The Earth Times (www.earthtimes.com) BSD Medical Corp. today announced the addition of seven new BSD-500 hyperthermia systems purchased by major cancer treatment center in the United States. The most recent purchase by the Massey Cancer Center at Virginia Commonwealth University located in Richmond, Virginia joins in a number of recent hyperthermia system [...]
Continue reading...3. July 2008
7/3/2008 web-based article staff MedicalNewsToday.com GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its human papillomavirus vaccine Cervarix until late 2009, Reuters reports. GSK said it has decided to wait until results from a Phase III trial of the vaccine are available before seeking U.S. approval. The study results likely will be submitted to [...]
Continue reading...1. July 2008
7/1/2008 Austin, TX staff Biocompare (news.biocompare.com) Mechanical engineering Assistant Professor Adela Ben-Yakar at The University of Texas at Austin has developed a laser “microscalpel” that destroys a single cell while leaving nearby cells intact, which could improve the precision of surgeries for cancer, epilepsy and other diseases. “You can remove a cell with high precision in 3-D without damaging the [...]
Continue reading...1. July 2008
7/1/2008 Chicago, IL D. Robert McCaffree, MD Chicago Tribune (www.chicagotribune.com) I read with interest the open letter from Dr. Brad Rodu to Sen. Obama in the June 22 Perspective section (”Quitting ins’t that easy”). In this open letter, Dr.Rodu advocated the use of smokeless and spit tobacco (which I will refer to only as spit tobacco) to reduce the [...]
Continue reading...1. July 2008
7/1/2008 Washingon, D.C. Matt Schudel Washington Post (www.washingpost.com) Clay S. Felker, the pioneering editor who founded New York magazine and helped launch the new journalism of the 1960s, with its novelistic techniques and strong point of view, died July 1 at his Manhattan home at 82. He had battled throat cancer in recent years. “He had beaten cancer three times,” [...]
Continue reading...30. June 2008
6/30/2008 Cardiff, Wales press release www.foxbusiness.com At the third annual conference on Advanced Digital Technology for Head and Neck Reconstruction today, SensAble Technologies, Inc, a leading provider of touch-enabled modeling solutions and haptic devices, and Majenta Solutions, an Authorized Reseller in the UK, showcased innovative uses of the FreeForm 3D modeling system for quickly creating patient-specific cranial and maxillofacial [...]
Continue reading...30. June 2008
6/30/2008 Cardiff, Wales Madeleine Brindley Wales Online (www.walesonline.co.uk) THE leader of the team which carried out the world’s first face transplant will lecture at a major international medical conference to be held in Cardiff. Professor Bernard Devauchelle, from Amiens, France, made international headlines in 2005 when his team carried out the world’s first face transplant on a 40-year-old French woman, [...]
Continue reading...
5. July 2008
0 Comments